ALKERMES | ALKS - PE Price to Earnings


ALKERMES reported $14.9 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie USD 18.41 69.26 Jun/2025
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
ALKERMES USD 14.9 1.11 Sep/2025
Amgen USD 9.49 3.02 Sep/2025
Biogen USD 9.38 3.02 Sep/2025
BioMarin Pharmaceutical USD 19.45 4.32 Sep/2025
Bristol-Myers Squibb USD 8.24 9.03 Sep/2025
Eli Lilly USD 37 7.55 Jun/2025
Gilead Sciences USD 15.72 0.32 Sep/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
J&J USD 23.62 0.86 Dec/2025
Malin Corporation EUR 11.81 0.72 Jun/2023
Merck USD 8.84 0.26 Sep/2025
Neurocrine Biosciences USD 33.27 9.34 Sep/2025
Otsuka Holdings JPY 8.92 0.03 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Vertex Pharmaceuticals USD 23.93 3.88 Sep/2025